Ozagrel
![]() | |
Systematic (IUPAC) name | |
---|---|
(2E)-3-[4-(1H-imidazol-1-ylmethyl)phenyl]acrylic acid | |
Clinical data | |
AHFS/Drugs.com | International Drug Names |
| |
Oral | |
Identifiers | |
82571-53-7 ![]() | |
None | |
PubChem | CID 5282440 |
ChemSpider |
4445594 ![]() |
UNII |
L256JB984D ![]() |
KEGG |
D08327 ![]() |
ChEMBL |
CHEMBL11662 ![]() |
Chemical data | |
Formula | C13H12N2O2 |
228.24 g/mol | |
SMILES
| |
| |
![]() |
Ozagrel (INN) is an antiplatelet agent working as a thromboxane A2 synthesis inhibitor.[1]